hGH fragment 176-191. Phase IIb oral trial (n=300) failed primary endpoint—no significant weight loss vs placebo. GRAS for food ingredient use is not drug approval.

📖 Read the full AOD-9604 research overview →

Evidence Tier: Tier 4 — Preclinical Only · Peptidings Verdict: Thin Ice